RhumbLine Advisers’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $247M | Buy |
2,385,158
+61,586
| +3% | +$5.5M | 0.19% | 78 |
|
|
2026
Q1 | $167M | Sell |
2,323,572
-75,296
| -3% | -$5.8M | 0.14% | 116 |
|
|
2025
Q4 | $190M | Buy |
2,398,868
+107
| +0% | +$8.44K | 0.15% | 104 |
|
|
2025
Q3 | $181M | Buy |
2,398,761
+8,598
| +0.4% | +$589K | 0.15% | 111 |
|
|
2025
Q2 | $165M | Sell |
2,390,163
-23,836
| -1% | -$1.56M | 0.14% | 121 |
|
|
2025
Q1 | $164M | Sell |
2,413,999
-238,429
| -9% | -$14.3M | 0.15% | 113 |
|
|
2024
Q4 | $119M | Buy |
2,652,428
+35,026
| +1% | +$1.96M | 0.11% | 154 |
|
|
2024
Q3 | $165M | Sell |
2,617,402
-48,638
| -2% | -$2.84M | 0.15% | 113 |
|
|
2024
Q2 | $157M | Sell |
2,666,040
-70,184
| -3% | -$4.39M | 0.15% | 116 |
|
|
2024
Q1 | $218M | Buy |
2,736,224
+14,203
| +0.5% | +$1.08M | 0.21% | 84 |
|
|
2023
Q4 | $215M | Buy |
2,722,021
+23,877
| +0.9% | +$1.7M | 0.23% | 82 |
|
|
2023
Q3 | $188M | Sell |
2,698,144
-14,322
| -0.5% | -$1.01M | 0.22% | 82 |
|
|
2023
Q2 | $188M | Buy |
2,712,466
+69,025
| +3% | +$4.91M | 0.21% | 88 |
|
|
2023
Q1 | $196M | Sell |
2,643,441
-25,838
| -1% | -$2.17M | 0.24% | 79 |
|
|
2022
Q4 | $249M | Buy |
2,669,279
+86,730
| +3% | +$8.37M | 0.33% | 51 |
|
|
2022
Q3 | $246M | Buy |
2,582,549
+77,353
| +3% | +$7.66M | 0.37% | 42 |
|
|
2022
Q2 | $232M | Buy |
2,505,196
+108,308
| +5% | +$10.6M | 0.34% | 52 |
|
|
2022
Q1 | $243M | Buy |
2,396,888
+66,678
| +3% | +$7M | 0.31% | 54 |
|
|
2021
Q4 | $240M | Sell |
2,330,210
-21,812
| -0.9% | -$2.02M | 0.29% | 57 |
|
|
2021
Q3 | $200M | Sell |
2,352,022
-63,883
| -3% | -$5.35M | 0.27% | 67 |
|
|
2021
Q2 | $202M | Sell |
2,415,905
-119,967
| -5% | -$9.82M | 0.26% | 71 |
|
|
2021
Q1 | $191M | Sell |
2,535,872
-116,302
| -4% | -$8.47M | 0.26% | 72 |
|
|
2020
Q4 | $181M | Buy |
2,652,174
+16,119
| +0.6% | +$1.05M | 0.25% | 72 |
|
|
2020
Q3 | $154M | Buy |
2,636,055
+15,706
| +0.6% | +$977K | 0.24% | 79 |
|
|
2020
Q2 | $170M | Buy |
2,620,349
+162,416
| +7% | +$10.2M | 0.28% | 65 |
|
|
2020
Q1 | $146M | Buy |
2,457,933
+40,955
| +2% | +$2.73M | 0.31% | 61 |
|
|
2019
Q4 | $180M | Buy |
2,416,978
+50,586
| +2% | +$3.55M | 0.3% | 62 |
|
|
2019
Q3 | $149M | Sell |
2,366,392
-38,205
| -2% | -$2.26M | 0.27% | 67 |
|
|
2019
Q2 | $131M | Buy |
2,404,597
+5,390
| +0.2% | +$290K | 0.25% | 74 |
|
|
2019
Q1 | $129M | Sell |
2,399,207
-75,590
| -3% | -$4.67M | 0.25% | 73 |
|
|
2018
Q4 | $162M | Buy |
2,474,797
+519,488
| +27% | +$38.8M | 0.35% | 53 |
|
|
2018
Q3 | $154M | Buy |
1,955,309
+49,013
| +3% | +$3.5M | 0.3% | 64 |
|
|
2018
Q2 | $123M | Sell |
1,906,296
-6,439
| -0.3% | -$424K | 0.25% | 73 |
|
|
2018
Q1 | $119M | Sell |
1,912,735
-1,961
| -0.1% | -$141K | 0.25% | 78 |
|
|
2017
Q4 | $139M | Buy |
1,914,696
+32,326
| +2% | +$2.35M | 0.28% | 65 |
|
|
2017
Q3 | $153M | Buy |
1,882,370
+8,297
| +0.4% | +$656K | 0.33% | 53 |
|
|
2017
Q2 | $151M | Buy |
1,874,073
+43,936
| +2% | +$3.47M | 0.34% | 48 |
|
|
2017
Q1 | $144M | Buy |
1,830,137
+19,759
| +1% | +$1.58M | 0.34% | 51 |
|
|
2016
Q4 | $143M | Buy |
1,810,378
+62,754
| +4% | +$5.08M | 0.36% | 50 |
|
|
2016
Q3 | $156M | Buy |
1,747,624
+43,353
| +3% | +$4.09M | 0.43% | 43 |
|
|
2016
Q2 | $163M | Buy |
1,704,271
+3,877
| +0.2% | +$386K | 0.48% | 42 |
|
|
2016
Q1 | $176M | Buy |
1,700,394
+60,455
| +4% | +$5.88M | 0.55% | 36 |
|
|
2015
Q4 | $160M | Sell |
1,639,939
-9,787
| -0.6% | -$959K | 0.52% | 36 |
|
|
2015
Q3 | $159M | Buy |
1,649,726
+10,236
| +0.6% | +$1.08M | 0.54% | 33 |
|
|
2015
Q2 | $172M | Sell |
1,639,490
-242,891
| -13% | -$24.8M | 0.55% | 32 |
|
|
2015
Q1 | $194M | Sell |
1,882,381
-55,625
| -3% | -$5.63M | 0.56% | 34 |
|
|
2014
Q4 | $187M | Sell |
1,938,006
-32,052
| -2% | -$2.82M | 0.54% | 36 |
|
|
2014
Q3 | $157M | Sell |
1,970,058
-73,951
| -4% | -$5.83M | 0.47% | 41 |
|
|
2014
Q2 | $154M | Sell |
2,044,009
-110,771
| -5% | -$8.37M | 0.45% | 42 |
|
|
2014
Q1 | $161M | Sell |
2,154,780
-34,145
| -2% | -$2.41M | 0.48% | 40 |
|
|
2013
Q4 | $157M | Sell |
2,188,925
-75,517
| -3% | -$4.85M | 0.46% | 41 |
|
|
2013
Q3 | $129M | Sell |
2,264,442
-12,862
| -0.6% | -$766K | 0.4% | 47 |
|
|
2013
Q2 | $130M | Buy |
+2,277,304
| New | +$132M | 0.42% | 42 |
|
Other funds holding CVS
RhumbLine Advisers's CVS Position: Q2 2026 in Review
RhumbLine Advisers increased its CVS Health (CVS) stake by 2.7% in Q2 2026, buying an estimated $5.5M and bringing the position to 2,385,158 shares worth $247M. The position accounts for 0.19% of the portfolio, ranked #78.
RhumbLine Advisers first reported a position in CVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $249M in Q4 2022. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- RhumbLine Advisers held 2,385,158 shares of CVS Health worth $247M as of Q2 2026.
- RhumbLine Advisers bought 61,586 CVS Health shares in Q2 2026, an estimated $5.5M.
- CVS Health made up 0.19% of RhumbLine Advisers's portfolio in Q2 2026, its #78 holding.
- RhumbLine Advisers first reported a position in CVS Health in Q2 2013 and has held it in 53 quarters since.
- RhumbLine Advisers's CVS Health position peaked at $249M in Q4 2022.
- 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.